School of Medicine
Showing 651-700 of 941 Results
-
Maneesh Kumar Misra
Clinical Associate Professor, Pathology
Current Research and Scholarly InterestsMy research goal is to utilize the cutting edge of stat of art histocompatibility testing to better understand the humoral and cellular responses in clinical transplantation, and to translate this knowledge into improved treatment, and transplant outcome.
-
Gabriel Mistelbauer
Senior Research Engineer, Rad/Cardiovascular Imaging
BioGabriel Mistelbauer is a senior research engineer in the Department of Radiology, Stanford University School of Medicine, Stanford, CA, USA, since 2022. Previously, he was a research associate at the Otto-von-Guericke University Magdeburg, Germany (2016-2022) and a postdoctoral researcher at TU Wien, Austria (2013-2016). He received a PhD in Computer Science, in the field of Medical Visualization, in 2013 at TU Wien, Austria, and the habilitation (venia legendi) in Computer Visualization (Computervisualistik) in 2024 at Otto-von-Guericke University Magdeburg, Germany. His research focuses on visual computing and image processing in medicine, in particular on the analysis of vascular structures.
-
Percy Khushroo Mistry
5717, Psych/Major Laboratories and Clinical & Translational Neurosciences Incubator
Current Role at StanfordResearch Scholar, Stanford Cognitive and Systems Neuroscience Laboratory
-
Tsuyoshi (Yoshi) Mitarai
Clinical Professor, Emergency Medicine
Current Research and Scholarly InterestsCritical Care, optimal resource allocations for inpatient care
-
Beverly S. Mitchell, M.D.
George E. Becker Professor of Medicine, Emerita
Current Research and Scholarly InterestsBeverly Mitchell's research relates to the development of new therapies for hematologic malignancies, including leukemias and myelodsyplastic syndromes. She is interested in preclinical proof of principle studies on mechanisms inducing cell death and on metabolic targets involving nucleic acid biosynthesis in malignant cells. She is also interested in the translation of these studies into clinical trials.
-
Donald Mitchell
Sr. Director, Academic Application Services, Technology & Digital Solutions
Current Role at StanfordDon Mitchell is the Director of the Academic Application Services (AAS) team in TDS. The AAS team focuses on the creation, integration, and deployment of web-based solutions for the Stanford University School of Medicine. We make use of a variety of hardware, software, and cloud technologies and partner closely with teams across TDS, the School of Medicine, and the University. We manage development, testing, and production environments, perform process mappings, set architecture standards, and provide consultations to teams looking to do software development or use SaaS solutions.
AAS' vision is to empower staff, faculty, and students with the integrated information, solutions, and IT resources needed to be successful and to support best-in-class administrative processes across the research and education missions. -
R. Scott Mitchell
Professor of Cardiothoracic Surgery at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsResearch Interests: Disease of the aorta, congenital and acquired. Treatment of aortic pathology, including development of stent graft systems. Patterns of disease in patients treated with mediastinal radiation. Valvular heart disease, especially aortopathy associated with congenital bicuspid aortic valve.
-
Anish Mitra
Assistant Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology)
BioAnish Mitra is a neuroscientist and psychiatrist interested in understanding how neural activity in large-scale networks causes mental illness.
-
Dr. Brita M Mittal, MD, FASA
Clinical Associate Professor, Anesthesiology, Perioperative and Pain Medicine
Current Research and Scholarly InterestsHead & Neck Anesthesiology
Advanced Airway Management
Epidermolysis Bullosa
Space Medicine -
Vaishali Mittal
Member, Maternal & Child Health Research Institute (MCHRI)
BioVaishali Mittal, MD is a Postdoctoral Clinical Fellow in the Department of Dermatology at Stanford University under the guidance of Dr. Jean Y. Tang.
Her current research is focused on epidermolysis bullosa (EB), a group of rare diseases that cause the skin and mucous membranes to blister easily. She is involved in conducting long-term clinical trials examining the application of an autologous, gene-corrected keratinocyte sheet for the treatment of recessive dystrophic EB (RDEB). In addition, she is currently leading several research projects, including investigation of genotype-phenotype associations in multiple subtypes of EB, creation of an online platform for EB patients/families and investigators to collaborate together on research, and development of an online genetic registry for EB patients using a novel, home-based genetic testing kit.
Vaishali received her medical degree from Stanford University School of Medicine and completed her internship at Beth Israel Deaconess Medical Center/Brockton Hospital. -
Masashi Miyauchi
Basic Life Research Scientist, Medicine - Med/Hematology
BioMasashi Miyauchi, MD, PhD, is a physician-scientist specializing in hematology, oncology, immunology, and stem cell biology, with over a decade of experience in clinical hematology and oncology. Dr. Miyauchi's academic career commenced at Kyoto University, where he obtained his MD in Medicine. He furthered his expertise with a PhD in Internal Medicine from The University of Tokyo, Graduate School of Medicine. Following his comprehensive clinical training and professional appointments at The University of Tokyo Hospital, Dr. Miyauchi embarked on a postdoctoral journey at Stanford University in the Nakauchi lab, starting in July 2019.
Dr. Miyauchi's clinical training is extensive, including a Senior Residency in Internal Medicine and a Clinical Fellowship in Hematology and Oncology at The University of Tokyo Hospital. This period was complemented by his participation in a Cancer Professional Training Plan. After completing his clinical fellowship, Dr. Miyauchi has served in various pivotal roles at The University of Tokyo Hospital and The University of Tokyo. His positions as a clinically-focused Project Assistant Professor and Assistant Professor in the Department of Hematology and Oncology have enabled him to contribute significantly to pioneering research and education for the next wave of medical professionals.
In his PhD research, Dr. Miyauchi specialized in the disease modeling of cancers and cancer stem cells, employing cancer patient-specific induced pluripotent stem cells (iPSCs). His work with iPSCs notably includes scalable ex vivo manufacturing of human neutrophils. In his postdoctoral research under the guidance of Dr. Hiromitsu Nakauchi in Genetics at Stanford, Dr. Miyauchi has been concentrating on developing a stable hematopoietic stem cell (HSC) expansion system in both mouse and human models. His research is focused on exploring the potential applications of this expansion system, underlining his commitment to advancing the fields of stem cell biology, regenerative medicine and oncology. -
Edward Mocarski
Professor of Microbiology and Immunology, Emeritus
Current Research and Scholarly InterestsMy research interests focused on the biology and pathogenesis of cytomegalovirus (CMV), an opportunistic pathogen that causes significant disease worldwide, reporting discoveries in areas of CMV gene regulation, DNA replication and packaging, maturation, impact on the host cell, disease pathogenesis, latency and reactivation, host cell death signaling and chemokine system. In the last 20 years of my academic career, we studied viral cell death suppressors and discovered ZBP1-RIPK3 necroptosis.
-
Daria Mochly-Rosen
George D. Smith Professor of Translational Medicine
Current Research and Scholarly InterestsTwo areas: 1. Using rationally-designed peptide inhibitors to study protein-protein interactions in cell signaling. Focus: protein kinase C in heart and large GTPases regulating mitochondrial dynamics in neurodegdenration. 2. Using small molecules (identified in a high throughput screens and synthetic chemistry) as activators and inhibitors of aldehyde dehydrogenases, a family of detoxifying enzymes, and glucose-6-phoshate dehydrogenase, in normal cells and in models of human diseases.
-
Everett J. Moding, MD, PhD
Assistant Professor of Radiation Oncology (Radiation Therapy)
Current Research and Scholarly InterestsMy laboratory performs translational research using analysis of human samples to identify critical mediators of treatment resistance that can be validated in preclinical models and targeted to enhance the efficacy of cancer therapy.
-
Siavash Moghadami
Ph.D. Student in Chemical and Systems Biology, admitted Summer 2022
BioSiavash Moghadami is a Ph.D. student in Chemical and Systems Biology at Stanford University School of Medicine, co-mentored by Professors Carolyn Bertozzi and Longzhi Tan. His work sits at the intersection of chemical biology, neuroscience, artificial intelligence (AI), and aging, with a long-term vision of building programmable brain–body physiology for healthy longevity so that fewer families have to watch their loved ones age in frailty.
Before Stanford, Siavash earned his B.Sc./M.Sc. in Biochemistry and Chemical Biology from the University of California, San Diego, graduating summa cum laude with highest departmental distinction and honors.
A proud immigrant pursuing the American dream, Siavash feels a profound sense of love and gratitude for the United States, which gave him a new home and a path into higher education and scientific discovery. His research on brain–body physiology and healthy longevity is, in many ways, his way of giving back—honoring the opportunities he found in America and working to protect the health and independence of his own and others’ loved ones. -
Islam Mohamed Nour Hassan Mohamed
Postdoctoral Scholar, Pediatric Surgery
BioDr. Islam Nour is a molecular virologist with over fifteen years of research experience spanning viral genomics, reverse genetics, and structural–functional analysis of pathogenic RNA viruses. As a previous postdoctoral fellow in Molecular Virology at USDA-ARS, he designed and deployed reverse-genetics systems for IBDV and avian reovirus, integrated Illumina and Oxford Nanopore sequencing with comparative genomics, and coupled these approaches to IHC/IF-based pathogenesis models. His earlier work on rotavirus and SARS-CoV spike evolution, protein modelling, and molecular viral surveillance further strengthened his ability to connect viral sequence variation to phenotypic outcomes and tissue injury. He is particularly motivated to bring this mechanistic and translational expertise to multidisciplinary clinical teams in pediatric liver disease and transplantation in division of pediatric surgery in Stanford Medicine, contributing rigorous viral pathogenesis, vector design, and protein expression skills to clinically relevant models and biomarker discovery.
-
Maha Abdalla Mohamed, MD, FACP, FAST
Clinical Associate Professor, Medicine - Nephrology
BioDr. Mohamed is a board-certified, fellowship-trained nephrologist with the Kidney and Pancreas Transplant Program at Stanford Healthcare. She is a clinical associate professor in the Department of Medicine, Division of Nephrology.
Dr. Mohamed specializes in kidney and pancreas transplant outcomes and kidney transplant health equity. Conditions she treats include allografts rejection, recipient BK virus and CMV infection, and post-transplant lymphoproliferative disorder management. Dr. Mohamed is known for her personalized and comprehensive approach to patient care. She takes the time to understand her patients’ unique health needs and creates tailored care plans that fit their lifestyles.
Dr. Mohamed’s research interests include examining new approaches to improving kidney transplant long-term outcome including kidney transplant rejection and infection. She also seeks to develop better screening and monitoring guidance to help reduce post-transplant BK virus and CMV infection.
Dr. Mohamed’s published work can be found in peer-reviewed journals such as Clinical Transplantation, Transplant Infectious Disease and Transplantation. She has presented to her peers at international, national, and regional meetings, including at the American Transplant Congress and the American Society of Nephrology. She has also been invited to speak multiple times at King Faisal Hospital in Rwanda as well as in Kingdom of Saudi Arabia on topics like post-transplant lymphoproliferative disorder, update in kidney transplant rejection, and update in living-donor kidney transplantation.
Dr. Mohamed is a faculty fellow of Stanford Center for Innovation in Global Health, fellow of the American Society of Transplantation, a board of managers member of the AST Transplant Nephrology Fellowship Training Accreditation Program, member of the International Society of Nephrology and the American Society of Nephrology. -
Ashu Mohammad
Postdoctoral Scholar, Urology
Basic Life Resear Scientist, Urology - DivisionsBioRecieved his PhD in molecular biology from Shoolini University, India. He is trying to understand the implications of oxidative stress and circadian rhythms in IC/BPS and Nocturia repectively.
